Noetik Secures $40M Series A to Advance Precision Cancer Therapies
Noetik, an AI-driven biotech firm using self-supervised machine learning and high-throughput spatial data to create cutting-edge cancer therapies, has announced the successful closure of an oversubscribed $40 million Series A…